论文部分内容阅读
目的:观察逍遥丸治疗儿童肠易激综合征的临床疗效。方法:观察组32例采用逍遥丸治疗,与空白对照组31例相比较,观察8周。结果:观察组和对照组的总有效率分别为84.38%,38.71%(P<0.01);逍遥丸在改善腹痛、腹胀及大便次数增多、排便不尽感及大便性状等方面均优于对照组,差异具有显著性意义;而在改善黏液便方面,两组差异不具显著性意义(P>0.05);逍遥丸能明显改善患儿肝郁脾虚证候,治疗前后证候积分比较具有显著性差异。结论:逍遥丸对于儿童肠易激综合征具有较好的临床疗效,并能有效改善肠易激综合征患者症状。
Objective: To observe the clinical efficacy of Xiaoyao Pill in treating children with irritable bowel syndrome. Methods: The observation group of 32 cases treated with Xiaoyao Pill, compared with the control group of 31 cases, observed for 8 weeks. Results: The total effective rates of the observation group and the control group were 84.38% and 38.71%, respectively (P <0.01). Xiaoyao Pill was superior to the control group in improving abdominal pain, abdominal distension and stool frequency, defecating indefiniteness and stool traits , The difference was significant; while in improving mucus, the difference between the two groups was not significant (P> 0.05); Xiaoyao Pills can significantly improve children with liver-qi and spleen deficiency syndrome, syndrome scores before and after treatment compared with significant differences . Conclusion: Xiaoyao Pills has good clinical efficacy in children with irritable bowel syndrome, and can effectively improve the symptoms of irritable bowel syndrome.